Key facts
- It has raised $330K; the latest was Seed Round ($330K) in May 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Incite Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Incite Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Incite Health
Operator of advanced clinical testing tool designed for improving clinical decision-making and personalized treatment strategies. The company integrates high-complexity laboratory services with state-of-the-art methodologies such as pharmacogenomic analysis, immune profiling, and infectious disease screening, offering customizable reports, rapid turnaround times, and actionable insights, enabling healthcare providers to enhance patient outcomes, reduce adverse drug reactions, and optimize medication management across diverse care settings.
- Sector
- Healthcare
- HQ
- Doylestown, PA, United States
- Employees
- 11
- Website
- incitehealth.com/
- Ownership
- Privately Held (backing)
Incite Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Incite Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Incite Health in its N-PORT filings yet. We sweep new filings monthly.